Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Terns Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 9,997 shares
@ $1.41, valued at
$14.1k
|
|
| 06/02/2023 |
4
| Yoon Seokho Bryan (COO and General Counsel) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 9,997 shares
@ $1.41, valued at
$14.1k
|
|
| 06/02/2023 |
4
| Sundaram Senthil Vel (CEO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 2,111 shares
@ $1.41, valued at
$3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 137,931 shares
@ $7.25, valued at
$1000k
|
|
| 12/28/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 137,931 shares
@ $7.25, valued at
$1000k
|
|
| 11/28/2022 |
4
| LAV Biosciences Fund V, L.P. (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Sold 1,000,000 shares
@ $5.5, valued at
$5.5M
Sold 333,334 shares
@ $5.5, valued at
$1.8M
Sold 166,666 shares
@ $5.5, valued at
$916.7k
|
|
| 09/08/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $3.6, valued at
$2.2M
|
|
| 09/08/2022 |
4
| Lu Hongbo (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 600,000 shares
@ $3.6, valued at
$2.2M
|
|
| 08/18/2022 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 2,470,200 shares
@ $2.42, valued at
$6M
Bought 457,400 shares
@ $2.42, valued at
$1.1M
Bought 762,400 shares
@ $2.42, valued at
$1.8M
Bought 207,500 options to buy
@ $0
Bought 38,450 options to buy
@ $0
Bought 64,050 options to buy
@ $0 |
|
| 08/18/2022 |
4
| GORDON CARL L (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 2,470,200 shares
@ $2.42, valued at
$6M
Bought 457,400 shares
@ $2.42, valued at
$1.1M
Bought 762,400 shares
@ $2.42, valued at
$1.8M
Bought 207,500 options to buy
@ $0
Bought 38,450 options to buy
@ $0
Bought 64,050 options to buy
@ $0 |
|
| 08/16/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 1,123,021 shares
@ $2.98, valued at
$3.3M
Bought 1,218 shares
@ $2.99, valued at
$3.6k
Bought 1,500,000 shares
@ $2.42, valued at
$3.6M
Bought 1,500,000 options to buy
@ $0.0001, valued at
$150 |
|
| 08/16/2022 |
4
| Lu Hongbo (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 1,123,021 shares
@ $2.98, valued at
$3.3M
Bought 1,218 shares
@ $2.99, valued at
$3.6k
Bought 1,500,000 shares
@ $2.42, valued at
$3.6M
Bought 1,500,000 options to buy
@ $0.0001, valued at
$150 |
|
| 07/28/2022 |
4
| Tripuraneni Radhika (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 64,000 options to buy
@ $2.13, valued at
$136.3k
|
|
| 07/28/2022 |
3
| Tripuraneni Radhika (Director) has filed a Form 3 on Terns Pharmaceuticals, Inc. |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Taylor Ann Elizabeth (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 32,000 options to buy
@ $1.82, valued at
$58.2k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Quirk Erin (President, CMO and Head of R&D) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 92,500 options to buy
@ $5.36, valued at
$495.8k
|
|
| 01/28/2022 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.36, valued at
$348.4k
|
|
| 01/28/2022 |
4
| Yoon Seokho Bryan (COO and General Counsel) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.36, valued at
$348.4k
|
|
| 01/28/2022 |
4
| Sundaram Senthil Vel (CEO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 280,000 options to buy
@ $5.36, valued at
$1.5M
|
|
| 10/12/2021 |
4
| Taylor Ann Elizabeth (Director) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 44,000 options to buy
@ $10.72, valued at
$471.7k
|
|
|
|
|